|
Provider Alert
Dear Provider,
Effective for claims with dates of service on and after April 1, 2015, Washington Apple Health (Medicaid), administered by the Health Care Authority (agency), will make the following changes to the Washington Preferred Drug List (WPDL).
|
Drug Class
|
Drug Name
|
Preferred Status
|
|
Combination Asthma Products
|
Anoro Ellipta®
|
Preferred
|
|
Breo Ellipta®
|
Preferred
|
|
Long-Acting Anticholinergics
(new drug class)
|
Spiriva Handihaler®
|
Preferred
|
|
Spiriva Respimat®
|
Preferred
|
|
Tudorza®
|
Non-preferred
|
|
PD4I Phosphodiesterase – 4 Inhibitors
(new drug class)
|
Daliresp®
|
Preferred
|
For more details, see the agency’s 30-day prerelease Washington Preferred Drug List (WPDL).
Thank you.
|
